nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
AAV2-GDNF Gene Delivery in Mild- and Moderate-Stages of Parkinson’s Disease: Preliminary Brain Imaging and Clinical Outcomes
|
Van Laar, A. |
|
|
122 |
C |
p. |
artikel |
2 |
Absence of causal relationship between Parkinson’s disease and subsequent prostate cancer: Evidence from meta-analysis and Mendelian randomization studies
|
Deng, J.-Y. |
|
|
122 |
C |
p. |
artikel |
3 |
A case of late onset PLA2G6-Associated neurodegeneration (Plan) with parkinsonism
|
Pak, T. |
|
|
122 |
C |
p. |
artikel |
4 |
A case of Parkinsonism with Niemann-Pick Type C Heterozygous Mutation
|
Bildirici, Ş. |
|
|
122 |
C |
p. |
artikel |
5 |
A case report of acute thrombocytopenia induced by Apomorphine in a patient with Parkinson's disease with motor fluctuations
|
Pocora, M.M. |
|
|
122 |
C |
p. |
artikel |
6 |
Accelerometric quantification of MDS-UPDRS bradykinesia measurements in PD patients: A pilot study
|
Smid, A. |
|
|
122 |
C |
p. |
artikel |
7 |
Accurate assessment of balance dysfunction in Parkinson's disease at different periods with Balance instruments
|
Zhao, Q. |
|
|
122 |
C |
p. |
artikel |
8 |
A comprehensive evaluation of the non-motor symptoms, quality of life and caregiver burden in patients with idiopathic dystonia
|
Gowda, N. |
|
|
122 |
C |
p. |
artikel |
9 |
Acute effect of levodopa on orthostatic hypotension and its association with motor responsiveness in Parkinson's disease
|
Liu, Z. |
|
|
122 |
C |
p. |
artikel |
10 |
Acute effect of levodopa on orthostatic hypotension and its association with motor responsiveness in Parkinson's disease
|
Liu, Z. |
|
|
122 |
C |
p. |
artikel |
11 |
Addressing Brain Circuit Dysfunction Underlying DBS-induced Parkinsonism
|
Martins, D. |
|
|
122 |
C |
p. |
artikel |
12 |
A Diagnostic Model for Parkinson’s Disease Based on Anoikis-Related Genes
|
Bao, Y. |
|
|
122 |
C |
p. |
artikel |
13 |
Adult-onset craniocervical dystonia associated with a monoallelic pathogenic AP4M1 variant and brain iron accumulation: A case report
|
Testini, P. |
|
|
122 |
C |
p. |
artikel |
14 |
Adult-onset dystonic opisthotonus associated with DLG4-related synaptopathy
|
De Santis, T. |
|
|
122 |
C |
p. |
artikel |
15 |
Advanced perspectives for the diagnosis of Parkinson’s and Alzheimer's disease through machine learning techniques
|
Malvaso, A. |
|
|
122 |
C |
p. |
artikel |
16 |
Age-related incidence of Parkinson's disease patients with Covid-19
|
Salimjonov, J. |
|
|
122 |
C |
p. |
artikel |
17 |
Age-specific prevalence of Parkinson’s disease and possible parkinsonian syndrome in Gaucher disease: Real-world evidence from the ICGG Gaucher Registry
|
Alcalay, R.N. |
|
|
122 |
C |
p. |
artikel |
18 |
A late-preterm neonate with germinal matrix hemorrhages and rapidly resolving abnormal vertical eye movements
|
Rachão, A. |
|
|
122 |
C |
p. |
artikel |
19 |
Alterations of neurotransmitters and metabolite levels in a rat model of orofacial dyskinesia
|
Kumar, A. |
|
|
122 |
C |
p. |
artikel |
20 |
A mouse model of Parkinson’s disease to understand the sex differences in pathological and behavioral outcomes
|
Subramanya, S.K. |
|
|
122 |
C |
p. |
artikel |
21 |
Analgesic effect of electroacupuncture on pain in Parkinson's disease and mechanism based on rs-fMRI
|
Zhu, S. |
|
|
122 |
C |
p. |
artikel |
22 |
Analysis of Parkinson's disease patients with Covid-19 by age and sex
|
Muminov, B. |
|
|
122 |
C |
p. |
artikel |
23 |
Analysis of risk factors affecting the development of vascular parkinsonism by gender
|
Amonov, B. |
|
|
122 |
C |
p. |
artikel |
24 |
An atypical case of head tremor
|
Angeloni, B. |
|
|
122 |
C |
p. |
artikel |
25 |
A new mutation for SCA38 or a huge coincidence?
|
Wiens, J. |
|
|
122 |
C |
p. |
artikel |
26 |
An observational study of Quality of Life in patients with Parkinson’s Disease pre and post DBS
|
Jayasree, M. |
|
|
122 |
C |
p. |
artikel |
27 |
An open-label, randomized, crossover, comparative bioavailability study of Levodopa Cyclops® and Inbrija® in healthy adult subjects
|
Hoppentocht, M. |
|
|
122 |
C |
p. |
artikel |
28 |
Anterior Attentional System Functioning in Patients with Parkinson’s Disease Across Various Cognitive Statutes
|
Golińska, P. |
|
|
122 |
C |
p. |
artikel |
29 |
Anti-alpha synuclein and anti-tau immunotherapies: Can a cocktail approach work?
|
del Giudice, Kirsys Patricia |
|
|
122 |
C |
p. |
artikel |
30 |
Anti-CASPR2 antibody-associated syndrome presenting with episodic ataxia
|
Lopes, S. |
|
|
122 |
C |
p. |
artikel |
31 |
An unsteady tale
|
Garg, D. |
|
|
122 |
C |
p. |
artikel |
32 |
An unusual cause of gait disturbance in a patient with Parkinson’s disease: Beware of mimics and chameleons
|
Fernandes, A. |
|
|
122 |
C |
p. |
artikel |
33 |
Application of motor rehabilitation programs in the normalization of the psycho-emotional sphere of patients with Parkinson`s disease
|
Voloshyn-Haponov, I. |
|
|
122 |
C |
p. |
artikel |
34 |
A prediction model for the progression of blepharospasm: A 4-year prospective cohort study
|
Xing, Z. |
|
|
122 |
C |
p. |
artikel |
35 |
A rare case of reversible hemidystonia in chronic hypoparathyroidism with extensive cerebral calcification
|
Kim, C.-W. |
|
|
122 |
C |
p. |
artikel |
36 |
Are genetic studies in Parkinson's disease necessary in clinical practice? Preliminary report of a cohort from Buenos Aires
|
Espindola, M. |
|
|
122 |
C |
p. |
artikel |
37 |
Are LRRK2 p.G2019S or GBA1 variants associated with long-term outcomes of deep brain stimulation for Parkinson’s disease?
|
Anis, S. |
|
|
122 |
C |
p. |
artikel |
38 |
Are peripheral α-synuclein isoforms biomarkers for diagnosis and prognosis of isolated REM sleep behavior disorder?
|
Arnaldo, L. |
|
|
122 |
C |
p. |
artikel |
39 |
Are the 5-2-1 Delphi criteria and MANAGE-PD useful screening tools for qualification to device-added therapies in advanced Parkinson’s disease?
|
Duda, K. |
|
|
122 |
C |
p. |
artikel |
40 |
Are there gender differences between subthalamic or globus pallidus internus DBS in Parkinson’s disease? Results from a single center
|
Belluscio, G. |
|
|
122 |
C |
p. |
artikel |
41 |
Associated Factors of Depression and Anxiety in Patients with Parkinson’s Disease
|
Ay, E. |
|
|
122 |
C |
p. |
artikel |
42 |
Association and Spatiotemporal Progression Patterns of Dopamine Availability and Deep Gray Matter Volume in Parkinson’s Disease–related Cognitive Impairment
|
Kim, J.-S. |
|
|
122 |
C |
p. |
artikel |
43 |
Association between autoimmune diseases and the risk of incident Parkinson's disease
|
Shang, H. |
|
|
122 |
C |
p. |
artikel |
44 |
Association between global cognitive function and autonomic dysfunction in patients with de novo Parkinson’s disease
|
Kwon, K.-Y. |
|
|
122 |
C |
p. |
artikel |
45 |
Association between global cognitive function and autonomic dysfunction in patients with de novo Parkinson’s disease
|
Kwon, K.-Y. |
|
|
122 |
C |
p. |
artikel |
46 |
Association between serum lipid levels and dopamine loss in idiopathic rapid eye movement sleep behavior disorder
|
Sun, Y. |
|
|
122 |
C |
p. |
artikel |
47 |
Association of Baseline Serum Urate Levels with Longitudinal General Cognition in Non-Demented Parkinson's Disease
|
Kim, S.J. |
|
|
122 |
C |
p. |
artikel |
48 |
Association of Glycated Hemoglobin (HbA1c) levels with Motor Symptoms in Parkinson’s Disease: A Cross-Sectional Investigation in the Indian Population
|
Choudhary, N. |
|
|
122 |
C |
p. |
artikel |
49 |
Association of small right vagus nerve cross-sectional area with abnormal heart rate variability
|
Lee, J. |
|
|
122 |
C |
p. |
artikel |
50 |
Asterixis resulting from neurosurgery
|
Palacino, F. |
|
|
122 |
C |
p. |
artikel |
51 |
A structural perspective on the interaction between glucocerebrosidase and the positive allosteric modulator BIA 28-6156
|
Dantas, J.M. |
|
|
122 |
C |
p. |
artikel |
52 |
Ataxia in Northern Canada: A Genetic Case Study
|
Villa Lopez, M. |
|
|
122 |
C |
p. |
artikel |
53 |
A Unique Case of Episodic Ataxia in SCA45: Unveiling a Novel FAT2 Variant
|
Makharia, A. |
|
|
122 |
C |
p. |
artikel |
54 |
Automated detection of REM Sleep Without Atonia: Description and Technical Evaluation
|
Levendowski, D. |
|
|
122 |
C |
p. |
artikel |
55 |
Autonomic dysfunction and motor progression in multiple system atrophy: A 1-year prospective cohort study
|
Huang, J. |
|
|
122 |
C |
p. |
artikel |
56 |
Baseline lipid traits and the clinical characteristics and disease progression in Huntington’s disease
|
Zhang, S. |
|
|
122 |
C |
p. |
artikel |
57 |
Blood Cholesterol Levels of Parkinson's Disease patients in Taksim Research and Training Hospital in İstanbul, Turkey
|
Tüncer, E.N. |
|
|
122 |
C |
p. |
artikel |
58 |
Botulinum toxin administration in Parkinson's Disease: Lateral trunk flexion suggesting early Pisa Syndrome
|
Cenacchi, V. |
|
|
122 |
C |
p. |
artikel |
59 |
Brain-first vs. body-first Parkinson's disease: An update on recent evidence
|
Horsager, Jacob |
|
|
122 |
C |
p. |
artikel |
60 |
Brain metabolic correlates of STN-DBS on gait in Parkinson’s disease: FDG-PET study of gait with dynamic obstacle avoidance
|
Hanafi, I. |
|
|
122 |
C |
p. |
artikel |
61 |
Burden and management of tardive dyskinesia (TD): An international survey to assess the perceptions and experiences of patients with TD
|
Ribalov, R. |
|
|
122 |
C |
p. |
artikel |
62 |
Burden, anxiety and depression among caregivers of Parkinson's patients
|
Alshoumar, A. |
|
|
122 |
C |
p. |
artikel |
63 |
Calcium channel blockers and Parkinson's disease: A systematic review and meta-analysis
|
Lin, J. |
|
|
122 |
C |
p. |
artikel |
64 |
Can a specific deep brain stimulation paradigm slow motor progression and provide long-term motor benefit in Parkinson’s disease?
|
Hacker, M.L. |
|
|
122 |
C |
p. |
artikel |
65 |
Can Baseline Diffusion Tensor Imaging Analysis Along the Perivascular Space Predict Motor Progression at 5 Years in Parkinson Disease?
|
Assaedi, E. |
|
|
122 |
C |
p. |
artikel |
66 |
Can α-synuclein oligomers in skin biopsies predict the worsening of cognition in Parkinson’s disease? A single-center longitudinal cohort study
|
Contaldi, E. |
|
|
122 |
C |
p. |
artikel |
67 |
Carrier Mediated Delivery System Bearing Dopamine for Effective Management of Parkinsonism
|
Bhargava, R. |
|
|
122 |
C |
p. |
artikel |
68 |
β-Caryophyllene decreases neuroinflammation and exerts neuroprotection of dopaminergic neurons in a model of hemiparkinsonism through inhibition of the NLRP3 inflammasome
|
Rubalcava, P.A. Brand |
|
|
122 |
C |
p. |
artikel |
69 |
Case Report: Jaw opening oromandibular dystonia with good response to isolated bilateral genioglossus botulinum toxin type A injections
|
Anang, J. |
|
|
122 |
C |
p. |
artikel |
70 |
Case report of a Parkinson’s disease patient with early motor fluctuation
|
Park, S. |
|
|
122 |
C |
p. |
artikel |
71 |
CasRm-mediated PTBP1 Knockdown Improves Motor Functions in Parkinson's Disease Mouse and Non-human Primate Models
|
Wang, S. |
|
|
122 |
C |
p. |
artikel |
72 |
Caudate dopamine loss, occipital hypoperfusion, and dementia conversion in Parkinson’s disease: A dual-phase 18F-FP-CIT PET Study
|
Chung, S.J. |
|
|
122 |
C |
p. |
artikel |
73 |
Cerebellar Ataxia, Parkinsonism and Peripheral Neuropathy in an Indian Family with MME Mutation
|
Desai, S. |
|
|
122 |
C |
p. |
artikel |
74 |
Cerebellar symptomatology following Covid-19 vaccination reveals breast cancer
|
Trpcheski, F. |
|
|
122 |
C |
p. |
artikel |
75 |
Cerebellopontine Angle Tumor Presenting with Hemifacial Spasm Attacks
|
Isiklar, C.O. |
|
|
122 |
C |
p. |
artikel |
76 |
Cerebrotendinous Xanthomatosis: Understanding Neurological Manifestations Through Physical Exam Video
|
Lopez, M. Villa |
|
|
122 |
C |
p. |
artikel |
77 |
Challenges during prayer (namaz/salah) rituals in Muslim patients with Parkinson’s disease
|
Çelik, B. |
|
|
122 |
C |
p. |
artikel |
78 |
Changes in NO-system parameters in vascular parkinsonism
|
Juraev, R. |
|
|
122 |
C |
p. |
artikel |
79 |
Changes of motor symptoms and regional cerebral blood flow after transcranial direct current stimulation in Parkinson's disease
|
Hwang, E. |
|
|
122 |
C |
p. |
artikel |
80 |
Changes of vagus nerve cross-sectional area as a disease-specific imaging biomarker in early Parkinson’s disease patients
|
Kang, J.H. |
|
|
122 |
C |
p. |
artikel |
81 |
Characterization of movement disorders in a cohort of hereditary cerebellar ataxias
|
Costa, S. |
|
|
122 |
C |
p. |
artikel |
82 |
Characterization of the pattern of daily motor fluctuations in Parkinson’s disease patients based on home diaries
|
Hauser, R.A. |
|
|
122 |
C |
p. |
artikel |
83 |
Characterizing Pain in Parkinson's Disease: Unveiling Types and Underlying Pathophysiology through a Scoping Review
|
Desai, D. |
|
|
122 |
C |
p. |
artikel |
84 |
Chorea-Acanthocytosis: A Case Report
|
Demir, S. |
|
|
122 |
C |
p. |
artikel |
85 |
Clinical – anatomical correlation of anti-dystonic effect in pallidal stimulation by advanced image reconstruction
|
Bejarano Hernandez, J.A. |
|
|
122 |
C |
p. |
artikel |
86 |
Clinical and genetic characteristics of PLA2G6-parkinsonism in southwest China and a review of heterogeneity of phenotype and genotype between Asian and Caucasian patients
|
Cheng, Y. |
|
|
122 |
C |
p. |
artikel |
87 |
Clinical and genetic factors affecting response to amantadine in Parkinson patients: Experience from a single tertiary center
|
Saadatpour, L. |
|
|
122 |
C |
p. |
artikel |
88 |
Clinical characteristics and mortality in Parkinson's disease patients with a history of fractures
|
Tawara, N. |
|
|
122 |
C |
p. |
artikel |
89 |
Clinical Evaluation of Parkinson's Disease Patients Admitted to the Movement Disorders Outpatient Clinic of Istanbul Taksim Training and Research Hospital, Turkey, 2023
|
Okutan, A.E. |
|
|
122 |
C |
p. |
artikel |
90 |
Clinical Overlap of Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) and Movement Disorders: Impact of Misdiagnosis on a Patient’s Journey
|
Meier, A. |
|
|
122 |
C |
p. |
artikel |
91 |
Clinical Phenomenology of Idiopathic and Acquired Adult-Onset Oromandibular Dystonia: From Onset to Spread
|
Trinchillo, A. |
|
|
122 |
C |
p. |
artikel |
92 |
Clinical profile of parkinsonism by molecular imaging of the brain (TRODAT and PET-CT)
|
Lavania, S. |
|
|
122 |
C |
p. |
artikel |
93 |
Clinical response and reduction in medication use after DBS surgery in a group of patients with Parkinson's disease in Colombia
|
López, T. |
|
|
122 |
C |
p. |
artikel |
94 |
Clinometric Profile of the Korean Version of Cognition Scales for Outcomes in Parkinson’s Disease
|
Park, J. |
|
|
122 |
C |
p. |
artikel |
95 |
Cognition in Multiple System Atrophy patients: The impact of sex and motor phenotype
|
Lazzeri, G. |
|
|
122 |
C |
p. |
artikel |
96 |
Cognition of Parkinson’s Disease Patients in the On and Off State: A Case Series
|
Brillman, S. |
|
|
122 |
C |
p. |
artikel |
97 |
Cognitive compromise in a cohort of patients from Colombia with DBS for Parkinson's disease treatment
|
López, T. |
|
|
122 |
C |
p. |
artikel |
98 |
Cognitive impairment in Parkinson's disease
|
Akbaralieva, S. |
|
|
122 |
C |
p. |
artikel |
99 |
Cognitive impairment in the underrepresented Latinx Parkinson disease population – Insights from the LARGE-PD and PPMI cohorts
|
Anis, S. |
|
|
122 |
C |
p. |
artikel |
100 |
Combined Assessment of GCase Activity and α-synuclein as a Promising Blood Biomarker for GBA Mutation Carriers
|
Pasquini, C. |
|
|
122 |
C |
p. |
artikel |
101 |
‘Comb sign' in mitochondrial membrane protein associated neurodegeneration: Revelation from 5 cases
|
Agarwal, A. |
|
|
122 |
C |
p. |
artikel |
102 |
Communication in Parkinson’s Disease and Healthy Controls: A Mixed-Methods Exploration of Conversational Speech Recordings in Natural Environments
|
Rountrey, C. |
|
|
122 |
C |
p. |
artikel |
103 |
Community-based participatory research approach to address health care disparities confronting members of the Black Diaspora with Parkinson’s disease
|
Pacheco, A. |
|
|
122 |
C |
p. |
artikel |
104 |
Comparative analysis of timings and errors in movements associated with Go and No-Go signals in Parkinson’s disease
|
Singh, H. |
|
|
122 |
C |
p. |
artikel |
105 |
Comparative profile of neurocognition and quality of life in Parkinson’s disease with and without psychosis
|
Baruah, T. |
|
|
122 |
C |
p. |
artikel |
106 |
Comparing brain activation in two subtypes of task-specific focal dystonia during dystonia-related and unrelated tasks: An fMRI study
|
Huynh, B.P. |
|
|
122 |
C |
p. |
artikel |
107 |
Comparison of spontaneous brain activity in distinguishing the parkinsonian variant of multiple system atrophy from Parkinson's disease at an early stage
|
Wang, S. |
|
|
122 |
C |
p. |
artikel |
108 |
Comprehensive analysis of information processing speed components in patients with Parkinson's disease
|
Alonso-Recio, L. |
|
|
122 |
C |
p. |
artikel |
109 |
Computational studies of compounds against alpha-synuclein in Kampavata AKA Parkinson's disease in Ayurveda
|
Rajpoot, S. |
|
|
122 |
C |
p. |
artikel |
110 |
Continuous subcutaneous levodopa/carbidopa infusion (ND0612) for patients with Parkinson’s disease and motor fluctuations: A Phase 3, active-controlled study (BouNDless)
|
Stocchi, F. |
|
|
122 |
C |
p. |
artikel |
111 |
Continuous subcutaneous levodopa/carbidopa infusion with ND0612 for Parkinson’s disease: Three-year data from the open-label BeyoND study
|
Stocchi, F. |
|
|
122 |
C |
p. |
artikel |
112 |
Could Irritable Bowel Syndrome be a Prodrome to Parkinson’s Disease? A Systematic Review
|
Lim, Y.L. |
|
|
122 |
C |
p. |
artikel |
113 |
Craniocervical synkinesias in movement disorder patients
|
Van Midden, V.M. |
|
|
122 |
C |
p. |
artikel |
114 |
CVN424, A novel GPR6 inverse agonist for the treatment of Parkinson disease (PD): Phase 2 clinical trial
|
Kieburtz, K. |
|
|
122 |
C |
p. |
artikel |
115 |
Dancing Out of Step: A Case of Tuberculous Meningitis Disguised as Childhood Chorea
|
Garcia, J.J. |
|
|
122 |
C |
p. |
artikel |
116 |
Deep Brain Stimulation of the Posterior Hypothalamus in Aggression Management – A Case Series Analysis
|
Poveda, S. |
|
|
122 |
C |
p. |
artikel |
117 |
Deep learning-based automatic REM sleep detection in patients with REM sleep behavior disorder: Is it reliable?
|
Jung, Y.J. |
|
|
122 |
C |
p. |
artikel |
118 |
Delphi Analysis: Anatomy and Botulinum Neurotoxin Type-A (BoNT-A) Injection Training for Spasticity and Dystonia
|
Heckert, K. |
|
|
122 |
C |
p. |
artikel |
119 |
Depressive disorder in Parkinson's disease
|
Akbaralieva, S. |
|
|
122 |
C |
p. |
artikel |
120 |
Depressive symptoms in advanced Parkinson`s disease
|
Petrić, D. |
|
|
122 |
C |
p. |
artikel |
121 |
Determination of Ambroxol Levels in Plasma and Cerebrospinal Fluid by Online Solid-Phase Extraction Coupled with Liquid Chromatography-Tandem Mass Spectrometry in GBA-Parkinson Disease Patients
|
Franco, V. |
|
|
122 |
C |
p. |
artikel |
122 |
Determination of hyperkinetic movement disorders during and after acute stroke
|
Qarshiboyeva, N. |
|
|
122 |
C |
p. |
artikel |
123 |
Developing and validating the new screening questionnaire for prodromal and Parkinson’s disease
|
Sringean, J. |
|
|
122 |
C |
p. |
artikel |
124 |
Development of a screening AI model for Parkinson's disease using gait image sequences
|
Youn, J. |
|
|
122 |
C |
p. |
artikel |
125 |
Diagnostic value and correlation analysis of serum cytokine levels in patients with multiple system atrophy
|
Chen, X. |
|
|
122 |
C |
p. |
artikel |
126 |
Differences in Dopamine Transporter Loss Pattern by DaTscan among patients with Parkinson's disease, Dementia with Lewy bodies and Parkinson's disease with dementia
|
Senoo, H. |
|
|
122 |
C |
p. |
artikel |
127 |
Differences in sleep behavior disorders between clinical types of idiopathic Parkinson’s disease
|
Lou, F. |
|
|
122 |
C |
p. |
artikel |
128 |
Differential roles of regional enlarged perivascular spaces in cognition and neuropsychiatric burden in drug-naive Parkinson’s disease
|
Na, H.K. |
|
|
122 |
C |
p. |
artikel |
129 |
Differential symptom cluster responses and predictors of response to repetitive transcranial magnetic stimulation treatment in Parkinson’s disease: A retrospective study
|
Sun, J. |
|
|
122 |
C |
p. |
artikel |
130 |
Digital devices and wearable technology for quantification of freezing of gait in adolescents with pediatric movement disorders attending school
|
Sharma, V. |
|
|
122 |
C |
p. |
artikel |
131 |
Disruption of the respiratory chain in the mitochondria of muscle cells in Parkinson’s disease
|
Abdiyeva, D. |
|
|
122 |
C |
p. |
artikel |
132 |
Does Deep Brain Stimulation worsen cognitive decline in GBA-Parkinson Disease patients? A longitudinal study of the Italian PARKNET cohort
|
AVENALI, M. |
|
|
122 |
C |
p. |
artikel |
133 |
Do lower doses of botulinum toxin offer a longer duration of effect and superior efficacy in patients with cervical dystonia?
|
Kundrick, A. |
|
|
122 |
C |
p. |
artikel |
134 |
Dopamine receptor D2 on CD4+ T cells is protective against neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease
|
Qiu, Y.-H. |
|
|
122 |
C |
p. |
artikel |
135 |
Dopaminergic System Changes in Visuomotor-Cognitive Multitasking Simulating Real-Life Mobility in Parkinson’s Disease
|
Bohnen, N. |
|
|
122 |
C |
p. |
artikel |
136 |
Dural arteriovenous fistula initially presenting as reversible asymmetric parkinsonism and improvement on dopamine transporter imaging after endovascular embolization treatment
|
Yoon, W.T. |
|
|
122 |
C |
p. |
artikel |
137 |
Duration of Botulinum Toxin Efficacy in Cervical Dystonia Clinical Trials: A Narrative Review
|
Castagna, A. |
|
|
122 |
C |
p. |
artikel |
138 |
Dystonia in the Middle East - The Cleveland Clinic Abu Dhabi Experience
|
Waqar, K. |
|
|
122 |
C |
p. |
artikel |
139 |
Editorial Board
|
|
|
|
122 |
C |
p. |
artikel |
140 |
Education level and the clinical characteristics and disease progression in Huntington’s disease: An Observational and Mendelian Randomization Study
|
Zhang, S. |
|
|
122 |
C |
p. |
artikel |
141 |
EEG biosignatures are sensitive and specific markers that distinctively characterize Parkinson's Disease, Lewy Body Dementia and Alzheimer's Disease
|
Berka, C. |
|
|
122 |
C |
p. |
artikel |
142 |
Effectiveness of botulinum toxin injections into the obliquus capitis inferior muscle for spasmodic torticollis
|
Doan, N. Luc |
|
|
122 |
C |
p. |
artikel |
143 |
Effect of deep brain stimulation of the subthalamic nucleus on the executive function in Parkinson’s disease
|
Slotwinski, K. |
|
|
122 |
C |
p. |
artikel |
144 |
Effect of long-term Tai Chi training on Parkinson’s disease: A 3.5-year follow-up cohort study
|
Li, G. |
|
|
122 |
C |
p. |
artikel |
145 |
Effect of Multimodal Intensive Rehabilitation Treatment on the Optimization of Dopaminergic Therapies in Patients with Moderately Advanced Parkinson’s Disease
|
McCrossin, M. |
|
|
122 |
C |
p. |
artikel |
146 |
Effect of opicapone and entacapone on early morning-OFF pattern in Parkinson’s disease patients with motor fluctuations
|
Videnovic, A. |
|
|
122 |
C |
p. |
artikel |
147 |
Effects of aerobic interval training on motor control mechanisms in people with Parkinson’s disease
|
Marusiak, J. |
|
|
122 |
C |
p. |
artikel |
148 |
Effects of a periodic continuous theta burst stimulation in Parkinson Disease
|
Hu, P. |
|
|
122 |
C |
p. |
artikel |
149 |
Effects of Baduanjin exercise on fine motor impairment of the fingers in Parkinson's disease
|
Li, J. |
|
|
122 |
C |
p. |
artikel |
150 |
Effects of Continuous Subcutaneous Infusion of Foslevodopa/Foscarbidopa on Sleep Dysfunction in People With Parkinson's
|
Hauser, R. |
|
|
122 |
C |
p. |
artikel |
151 |
Effects of DLPFC tDCS followed by treadmill training on dual-task gait and cortical excitability in Parkinson's disease: A randomized controlled trial
|
Wong, P.-L. |
|
|
122 |
C |
p. |
artikel |
152 |
Effects of Periventricular White Matter Lesions on PD Cognitive Deficits are Mediated by Limbic Cholinergic Deficits in PD
|
Carli, G. |
|
|
122 |
C |
p. |
artikel |
153 |
Effects of Sleep Hygiene on Sleep Disturbance in Patients with Parkinsonism
|
Yun, J.Y. |
|
|
122 |
C |
p. |
artikel |
154 |
Efficacy and safety of foslevodopa/foscarbidopa continuous subcutaneous infusion administered as monotherapy in patients with Parkinson’s disease
|
Aldred, J. |
|
|
122 |
C |
p. |
artikel |
155 |
Efficacy and safety of foslevodopa/foscarbidopa subcutaneous infusion in patients with prior deep brain stimulation
|
Henriksen, T. |
|
|
122 |
C |
p. |
artikel |
156 |
Efficacy of Once-Daily Valbenazine in Adults with Chorea Associated with Huntington’s Disease: Effect Size Over Time
|
Stimming, E. Furr |
|
|
122 |
C |
p. |
artikel |
157 |
Elderly-onset severe parkinsonism in Wilson Disease: A case report
|
Li, K.-F. |
|
|
122 |
C |
p. |
artikel |
158 |
Electroacupuncture alleviates pain in Parkinson's disease by modulating the microglia-NLRP3 inflammasome-inflammatory factor axis
|
Wang, X.-W. |
|
|
122 |
C |
p. |
artikel |
159 |
Electroacupuncture alleviates pain in Parkinson's disease by modulating the microglia-NLRP3 inflammasome-inflammatory factors axis
|
Wang, X.-W. |
|
|
122 |
C |
p. |
artikel |
160 |
Elevated salivary copper levels in patients with Wilson's disease
|
Bonilha, P.A.A.M. |
|
|
122 |
C |
p. |
artikel |
161 |
Emerging role of rolipram in orofacial dyskinesia in a haloperidol-induced rat model via downregulation of oxidative stress and alteration in neurotransmitters
|
Saroj, S. |
|
|
122 |
C |
p. |
artikel |
162 |
Enhanced low beta activity in Park2-associated Parkinson’s disease
|
Filyushkina, V. |
|
|
122 |
C |
p. |
artikel |
163 |
Enlarged perivascular space in the temporal lobe as a predictor for cerebral amyloidosis in Lewy body disease
|
Na, H.K. |
|
|
122 |
C |
p. |
artikel |
164 |
Epidemiological Disparities and Challenges in Non-Parkinsonian Tremor Disorders Research
|
Desai, S. |
|
|
122 |
C |
p. |
artikel |
165 |
Epigenome-wide DNA methylation signatures of excessive daytime sleepiness in Parkinson's Disease: Analysis of the PPMI Cohort
|
Yang, T. |
|
|
122 |
C |
p. |
artikel |
166 |
Essential Tremor Diagnosis Accuracy: 1998 versus 2018 Movement Disorder Society Consensus
|
Sandulescu, M.C. |
|
|
122 |
C |
p. |
artikel |
167 |
Establishing exercise habits in patients with Parkinson's disease through an exercise group model
|
LU, Y. |
|
|
122 |
C |
p. |
artikel |
168 |
Estrogen Derivatives and Neuroprotection in Parkinson's Disease: A Machine Learning Analysis of Hormone Therapy Effects in Transgender Women
|
Fajar, R. |
|
|
122 |
C |
p. |
artikel |
169 |
Evaluation of autonomic, imaging and genetic biomarkers for dementia in Parkinson’s disease: A cohort description
|
Polverino, P. |
|
|
122 |
C |
p. |
artikel |
170 |
Evolution in Functionality of People with Parkinson's Disease: Gender Influence
|
Dias, R.A. |
|
|
122 |
C |
p. |
artikel |
171 |
Evolution of Cervical Dystonia (CD) Phenotypes in Patients Treated with Botulinum Toxin
|
Trinchillo, A. |
|
|
122 |
C |
p. |
artikel |
172 |
Examination of cognitive function in Parkinson's disease patients with chronic kidney disease
|
Khudayarova, S. |
|
|
122 |
C |
p. |
artikel |
173 |
Executive dysfunction, discourse deficits, and responsiveness to transcranial direct current stimulation in patients with atypical Parkinsonian disorders
|
Scholtz, J. |
|
|
122 |
C |
p. |
artikel |
174 |
Executive function in patients with Parkinson disease
|
Slotwinski, K. |
|
|
122 |
C |
p. |
artikel |
175 |
Exploration of potential immune mechanisms in cervical dystonia
|
Scorr, Laura M. |
|
|
122 |
C |
p. |
artikel |
176 |
Exploring gait-related neural activity recorded from the subthalamic nucleus in Parkinson Disease
|
Liao, J. |
|
|
122 |
C |
p. |
artikel |
177 |
Exploring Levodopa-induced dyskinesia in Latin American Parkinson`s disease patients: Insights from the large-PD Consortium
|
Chaparro-Solano, H.M. |
|
|
122 |
C |
p. |
artikel |
178 |
Exploring Mitochondrial DNA Damage in Neuronal Complex I Deficient Parkinson's Neurons
|
Rubiolo, A. |
|
|
122 |
C |
p. |
artikel |
179 |
Exploring Mitochondrial DNA Damage in Neuronal Complex I Deficient Parkinson's Neurons
|
Rubiolo, A. |
|
|
122 |
C |
p. |
artikel |
180 |
Exploring obstructive sleep apnea and sleep architecture in Parkinson's disease motor subtypes
|
Scanga, Amanda |
|
|
122 |
C |
p. |
artikel |
181 |
Exploring the clinico-ophthalmologic profile of patients with presumed genetically-determined dystonia
|
Dhar, D. |
|
|
122 |
C |
p. |
artikel |
182 |
Exploring the efficacy and challenges of Levodopa-Carbidopa Intestinal Gel in treating patients with Multiple System Atrophy: Experience of two centers
|
Lopes, S. |
|
|
122 |
C |
p. |
artikel |
183 |
Exploring the impact of antidepressants on depression in Parkinson’s disease
|
Saxena, S. |
|
|
122 |
C |
p. |
artikel |
184 |
Exploring the Role of Genetic Mutations and Clinical Features in the Conversion to α-Synucleinopathies
|
Qin, J. |
|
|
122 |
C |
p. |
artikel |
185 |
Exploring the Role of Genetic Mutations and Clinical Features in the Conversion to α-Synucleinopathies
|
Qin, J. |
|
|
122 |
C |
p. |
artikel |
186 |
Extended-release amantadine for OFF-related dystonia in Parkinson's disease
|
Espay, Alberto J. |
|
|
122 |
C |
p. |
artikel |
187 |
Extra-Striatal Cholinergic System Changes in Dopamine Replacement Therapy Responsive versus Non-Responsive Freezing of Gait in Parkinson's Disease: [18F]-FEOBV PET study
|
Kanel, P. |
|
|
122 |
C |
p. |
artikel |
188 |
Factors influencing functionality in individuals with Parkinson`s disease
|
Libard, E. |
|
|
122 |
C |
p. |
artikel |
189 |
Features of pallidal single unit activity in myoclonus dystonia
|
Sedov, A. |
|
|
122 |
C |
p. |
artikel |
190 |
Fecal microbiota transplantation for Parkinson’s disease (FMT4PD): A safety and feasibility pilot study
|
Chernova, V.O. |
|
|
122 |
C |
p. |
artikel |
191 |
Fibrinogen exacerbates GCase ubiquitination via ATF5-induced TRIP12 activation in Parkinson's Disease
|
Zhong, H. |
|
|
122 |
C |
p. |
artikel |
192 |
First-year Treatment Intensity and Prognosis in Early Parkinson’s Disease: A Retrospective, Longitudinal Study in Israel
|
Barer, Y. |
|
|
122 |
C |
p. |
artikel |
193 |
Focal task-specific hand dystonia related to esports in a rhythm gamer: A case report
|
Kawama, K. |
|
|
122 |
C |
p. |
artikel |
194 |
Frailty and autonomic insufficiency
|
Ovchynnykova, A. |
|
|
122 |
C |
p. |
artikel |
195 |
Frequency of GAA-FGF14 ataxia in a large cohort of Brazilian patients with unsolved adult-onset cerebellar ataxia
|
Novis, L.E. |
|
|
122 |
C |
p. |
artikel |
196 |
Friend or Foe? Experiences and Expectations Pertaining to the Use of Artificial Intelligence (AI) in the Field of Movement Disorders
|
Mari, Z. |
|
|
122 |
C |
p. |
artikel |
197 |
From Writer's Cramp to Blepharoclonus: An Atypical Journey with a Novel KMT2B Variant
|
Makharia, A. |
|
|
122 |
C |
p. |
artikel |
198 |
Frontotemporal dementia associated with SQSTM1 gene mutation and lower amyloid beta 1-42
|
Angelova, A. |
|
|
122 |
C |
p. |
artikel |
199 |
Functional constipation is associated with motor response complications in Parkinson's disease
|
Lau, Y.H. |
|
|
122 |
C |
p. |
artikel |
200 |
Functional or dystonic tremor? The answer is in electrophysiological tremor recording
|
Grneva, M. |
|
|
122 |
C |
p. |
artikel |
201 |
Gait and speech improvement in one patient following 3-months of adaptive STN-DBS therapy
|
Palmisano, C. |
|
|
122 |
C |
p. |
artikel |
202 |
Gait difficulty in a young female - a rare cause should not be missed
|
Vo, K.N.C. |
|
|
122 |
C |
p. |
artikel |
203 |
GBA1-and LRRK2-directed Treatments: The Way Forward
|
Maayan Eshed, Gadi |
|
|
122 |
C |
p. |
artikel |
204 |
Gender Disparities in Parkinson's Disease: Exploring Quality of Life Among Mexican Men and Women (2011-2019)
|
Hernández-Medrano, A.J. |
|
|
122 |
C |
p. |
artikel |
205 |
Gender, Race and Socioeconomic Disparities on Initiation of Surgical Device-Aided Therapies (DATs) Among Medicare Beneficiaries with advanced Parkinson’s Disease (aPD)
|
Fernandez, H.H. |
|
|
122 |
C |
p. |
artikel |
206 |
Genetically Proven Familial Huntington’s Disease in the Philippines: A Case Series
|
Garcia, J.J. |
|
|
122 |
C |
p. |
artikel |
207 |
Genetic literacy of patients with Parkinson’s disease and their caregivers, and attitudes toward genetic testing: A review
|
Kamath, S. |
|
|
122 |
C |
p. |
artikel |
208 |
Genetic Screening in Patients with Parkinson Disease and Deep Brain Stimulation
|
Assaedi, E. |
|
|
122 |
C |
p. |
artikel |
209 |
Genetic Variability in Parkinson's Disease: A2M Gene Mutations Examined in a Cohort of 179 Patients with Familial and Early-Onset Forms
|
Scanni, M.D. |
|
|
122 |
C |
p. |
artikel |
210 |
Genetic variability of OBPIIa in Parkinson’s Disease (PD) patients of Tamil Nadu population, India
|
Venkatesan, D. |
|
|
122 |
C |
p. |
artikel |
211 |
Global presence of CSF1R-Related disorder: A case series from North and South America, Asia and Europe
|
Dulski, J. |
|
|
122 |
C |
p. |
artikel |
212 |
GNB1 mutation - A (not so) rare cause for early onset dystonia
|
Novotni, G. |
|
|
122 |
C |
p. |
artikel |
213 |
Groningen Early-PD Ambroxol Treatment (GREAT) Trial: A randomized, double-blind, placebo-controlled trial of ambroxol in Parkinson patients with a GBA-mutation (protocol)
|
Siemeling, O. |
|
|
122 |
C |
p. |
artikel |
214 |
Ground Reaction Force Analysis in Parkinson’s Disease and Freezing of Gait. A secondary analysis of a gait-analysis data set
|
Etoom, M. |
|
|
122 |
C |
p. |
artikel |
215 |
Gut changes as potential trigger for Parkinson's disease
|
Syvänen, V. |
|
|
122 |
C |
p. |
artikel |
216 |
Gut microbiota modification with rifaximin modulates severity of symptoms of Parkinson’s disease with concomitant small intestinal bacterial overgrowth
|
Korbecka, J. |
|
|
122 |
C |
p. |
artikel |
217 |
Head Position During Sleep: Potential Implications for Patients with Neurodegenerative Disorders
|
Levendowski, D. |
|
|
122 |
C |
p. |
artikel |
218 |
Healthcare education program in multiple system atrophy: Safety, quality and satisfaction from a national registry-based longitudinal study
|
Camara, A. |
|
|
122 |
C |
p. |
artikel |
219 |
Hereditary Spastic Paraparesis with SPG6 mutation: First case report from Malaysia
|
Lau, Y.H. |
|
|
122 |
C |
p. |
artikel |
220 |
High-fat diet as a predisposing factor to Parkinson disease via interplay between inflammation and autophagy in a murine model
|
Júlio de Souza, A.L. |
|
|
122 |
C |
p. |
artikel |
221 |
Hospice Guidelines for Parkinson’s Disease and Related Disorders: Lessons Learned from a Palliative Program
|
Chan, J. |
|
|
122 |
C |
p. |
artikel |
222 |
How clinicians inform patients with Parkinson’s disease about levodopa and involve them in decisions to initiate treatment
|
Kurpershoek, E. |
|
|
122 |
C |
p. |
artikel |
223 |
How to dose extended-release carbidopa-levodopa capsules (IPX203) in Parkinson’s disease patients: Experience from the phase 3 clinical trial
|
Hauser, R.A. |
|
|
122 |
C |
p. |
artikel |
224 |
‘Hung-up’ knee jerk as an initial diagnostic clue of Huntington disease
|
Lau, K.M. |
|
|
122 |
C |
p. |
artikel |
225 |
Huntington disease – Update on ongoing therapeutic developments and a look toward the future
|
Sampaio, Cristina |
|
|
122 |
C |
p. |
artikel |
226 |
Huntington Disease – Update on Recent Advances and a Look Toward the Future
|
Sampaio, C. |
|
|
122 |
C |
p. |
artikel |
227 |
Identification of the needs of patients with Parkinson’s disease through a qualitative research process
|
Vanchinathan, V. |
|
|
122 |
C |
p. |
artikel |
228 |
If You Don’t Ask, You Won’t Know: Inclusive Recruitment Strategies for the Parkinson Progression Markers Initiative (PPMI)
|
Mantri, S. |
|
|
122 |
C |
p. |
artikel |
229 |
Iluzanebart Phase 2, IGNITE Study: First Interventional Study in Patients with Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP)
|
Lynch, D. |
|
|
122 |
C |
p. |
artikel |
230 |
Immersive virtual reality as a complement to physical therapy for Parkinson’s disease – A randomized controlled trial
|
Silva, D. Pimenta |
|
|
122 |
C |
p. |
artikel |
231 |
Impact of COVID-19 on Parkinson's disease: A comprehensive analysis
|
Yuldasheva, N. |
|
|
122 |
C |
p. |
artikel |
232 |
Impact of Falls on Quality of Life among Patients with Parkinson’s Disease from a Referral Center Ambulatory Care PD Clinic
|
Yu, J.R.T. |
|
|
122 |
C |
p. |
artikel |
233 |
Impact of Rivastigmine on Gait in Patients with Neurodegenerative Disorders: A Systematic Review and Meta-analysis
|
Lee, S.-M. |
|
|
122 |
C |
p. |
artikel |
234 |
Impaired contrast sensitivity performance in freezers and fallers in Parkinson’s disease
|
Brown, T. |
|
|
122 |
C |
p. |
artikel |
235 |
Implications of midbrain perivascular space in REM sleep behavior disorder and motor progression in drug-naïve Parkinson’s disease
|
Ha, J. |
|
|
122 |
C |
p. |
artikel |
236 |
Improvement of non-motor symptoms with NE3107 adjunctive to Carbidopa / Levodopa in patients with Parkinson`s disease: A Phase 2A, placebo-controlled study
|
Palumbo, J. |
|
|
122 |
C |
p. |
artikel |
237 |
Improving Quality and Safety of Care for Hospitalized People with Parkinson’s Disease – Results of Six Months of Proactive Intervention
|
Piccinin, C.C. |
|
|
122 |
C |
p. |
artikel |
238 |
Influence of electrode distance from target and stimulation current on the effect of STN-DBS
|
Rouleau, E.A.M.Y. |
|
|
122 |
C |
p. |
artikel |
239 |
Integrity of Dopaminergic Terminals in the Caudate Nucleus Modulates Rest Tremor in Parkinson’s Disease
|
Mendonça, M. |
|
|
122 |
C |
p. |
artikel |
240 |
Integrity of Dopaminergic Terminals in the Caudate Nucleus Modulates Rest Tremor in Parkinson’s Disease
|
Mendonça, M. |
|
|
122 |
C |
p. |
artikel |
241 |
Interaction between caffeine intake and polymorphisms of MCCC1 modifies Parkinson’s Disease risk
|
Yang, Y. |
|
|
122 |
C |
p. |
artikel |
242 |
Interaction between caffeine intake and polymorphisms of PARK16 modifies Parkinson’s Disease risk
|
Tan, E.K. |
|
|
122 |
C |
p. |
artikel |
243 |
Interaction between sex and GBA mutations influences clinical phenotype in Parkinson disease
|
Gallo, L. |
|
|
122 |
C |
p. |
artikel |
244 |
Interdisciplinary insights into tremor in dystonia: Navigating clinical controversies, definitional challenges, and pathophysiological complexities
|
Shaikh, Aasef G. |
|
|
122 |
C |
p. |
artikel |
245 |
Intranasal delivery of insulin for the restoration of memory signaling in Alzheimer's disease
|
Nema, T. |
|
|
122 |
C |
p. |
artikel |
246 |
Intronic GAA-FGF14 Expansion in an italian patient presenting with early-onset cerebellar ataxia
|
Mitrotti, P. |
|
|
122 |
C |
p. |
artikel |
247 |
Investigating Altered Cerebral Blood Flow Patterns in Idiopathic Cervical Dystonia: A Study Using Single Photon Emission Computed Tomography (SPECT)
|
Kim, B. |
|
|
122 |
C |
p. |
artikel |
248 |
In vivo and in vitro effects of resveratrol in experimental models of Parkinson's disease
|
Kumar, R. |
|
|
122 |
C |
p. |
artikel |
249 |
Is Dystonia an Immunologic Disorder?
|
Jankovic, Joseph |
|
|
122 |
C |
p. |
artikel |
250 |
Lack of association between ARSA rare variants and Parkinson’s disease
|
Wang, S. |
|
|
122 |
C |
p. |
artikel |
251 |
Lactic Acid Conjugated SLN for Effective Management of Neurocysticercosis
|
Bhargava, V. |
|
|
122 |
C |
p. |
artikel |
252 |
Levodopa-induced dyskinesia isolated to the abdomen in advanced Parkinson’s disease with longstanding high-dose levodopa exposure: A case report
|
Nguyen, M. |
|
|
122 |
C |
p. |
artikel |
253 |
Levodopa-responsive spastic paraparesis associated with a pathogenic variant in GCH1
|
Costa, S. |
|
|
122 |
C |
p. |
artikel |
254 |
Lithium toxicity presented as parkinsonism and ataxia
|
Angelova, A. |
|
|
122 |
C |
p. |
artikel |
255 |
Longitudinal brain changes in Parkinson's disease with severe olfactory deficit
|
Kawabata, Kazuya |
|
|
122 |
C |
p. |
artikel |
256 |
Longitudinal change in brain function and structure related to plasma neurofilament light protein in early-stage Parkinson’s disease
|
Xiao, Y. |
|
|
122 |
C |
p. |
artikel |
257 |
Longitudinal evolution and plasma biomarkers for excessive daytime sleepiness in Parkinson's disease
|
Lin, J. |
|
|
122 |
C |
p. |
artikel |
258 |
Looking Beyond the Brain: Insights into Vascular Parkinsonism with Optical Coherence Tomography
|
Agrawal, A. |
|
|
122 |
C |
p. |
artikel |
259 |
Loss of monomeric alpha-synuclein (synucleinopenia) and the origin of Parkinson's disease
|
Espay, Alberto J. |
|
|
122 |
C |
p. |
artikel |
260 |
Low urinary tract dysfunction and motor severity in patients with multiple system atrophy
|
Ha, U.N.L. |
|
|
122 |
C |
p. |
artikel |
261 |
Machine Learning Analysis of the Interaction Between miR-155 and LRRK2 Gene Variants in Parkinson's Disease Progression
|
Fajar, R. |
|
|
122 |
C |
p. |
artikel |
262 |
Magnetic Resonance Imaging Marker for the Conversion from Idiopathic Late-onset Cerebellar Ataxia to Multiple System Atrophy
|
Lee, J.S. |
|
|
122 |
C |
p. |
artikel |
263 |
Mapping brain metabolism, connectivity and neurotransmitters topography in early and late onset dementia with lewy bodies
|
Caminiti, Silvia Paola |
|
|
122 |
C |
p. |
artikel |
264 |
MAPT c.1999-1G> A Mutation presenting as Dysexecutive variant AD with CBS phenotype
|
Mustafa, F. |
|
|
122 |
C |
p. |
artikel |
265 |
Masticatory-Induced Ocular Task-Specific Dystonia
|
Zheng, X. |
|
|
122 |
C |
p. |
artikel |
266 |
Maximum dose of AbobotulinumtoxinA: Is there room for more?
|
Amarante, D. |
|
|
122 |
C |
p. |
artikel |
267 |
Melatonin protects against Parkinson's disease via regulating the activation of NLRP3 inflammasome mediated by TLR2
|
Wang, X. |
|
|
122 |
C |
p. |
artikel |
268 |
Mental health in Parkinson’s: Uncovering real-world patient experiences in psychological support and care
|
Hunsdon, R. |
|
|
122 |
C |
p. |
artikel |
269 |
Metabolic Syndrome and Non-Motor Symptom Fluctuations in Parkinson's Disease
|
Regalado-Mustafa, A.Y. |
|
|
122 |
C |
p. |
artikel |
270 |
Method for assessing function of the segmental apparatus of the autonomic nervous system using magnetic stimulation
|
Radjabova, K. |
|
|
122 |
C |
p. |
artikel |
271 |
Mild Behavioral Impairment in Lewy body disease: A potential marker of phenoconversion and disease severity
|
Jin, B. |
|
|
122 |
C |
p. |
artikel |
272 |
Modulation of neural activity in response to dance training in Parkinson’s: A case study
|
Simon, R. |
|
|
122 |
C |
p. |
artikel |
273 |
Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation
|
Stampanoni Bassi, Mario |
|
|
122 |
C |
p. |
artikel |
274 |
Moving Ear Syndrome: A rare and treatable phenomenon
|
Yahya, V. |
|
|
122 |
C |
p. |
artikel |
275 |
MR-guided focused ultrasound in movement disorders and beyond: Lessons learned and new frontiers
|
Natera-Villalba, Elena |
|
|
122 |
C |
p. |
artikel |
276 |
Multidimensional factors can affect the Sexual Health of men with Parkinson's disease
|
Piemonte, M.E. Pimentel |
|
|
122 |
C |
p. |
artikel |
277 |
Multidimensional factors can affect the sexual health of women living with Parkinson's disease
|
Piemonte, M.E. Pimentel |
|
|
122 |
C |
p. |
artikel |
278 |
Multiple system atrophy like presentation with hot-cross bun sign in anti-IgLON5 disease
|
Vijayaraghavan, Asish |
|
|
122 |
C |
p. |
artikel |
279 |
Muscle-targeted nutritional support and rehabilitation (MIRT) to treat Parkinsonian patients with risk of fall: A multicentric, randomized, single-blind study
|
Frazzitta, G. |
|
|
122 |
C |
p. |
artikel |
280 |
Nebulized Administration of Roasted Mucuna Powder Using a Hydrogen Water Superheated System in Parkinson's Disease
|
Neshige, R. |
|
|
122 |
C |
p. |
artikel |
281 |
Neuronal Intranuclear Inclusion Disease presenting with ataxia and parkinsonism
|
De Santis, T. |
|
|
122 |
C |
p. |
artikel |
282 |
Neuroprotective Activity of Ethanolic Extract of Sesuvium Portulacastrum Against Haloperidol Induced Parkinson’s Disease Model
|
Rajput, R. |
|
|
122 |
C |
p. |
artikel |
283 |
Neuroprotective and antioxidant potential of Moringa oleifera leaf extract in a murine model of Parkinson's disease
|
Kumar, A. |
|
|
122 |
C |
p. |
artikel |
284 |
Neuroprotective potential of nanoparticles of cinnamaldehyde on oxidative stress in nigrostriatal tissue and neurobehavioral characteristics in a rat model of Parkinson’s disease
|
Rajput, R. |
|
|
122 |
C |
p. |
artikel |
285 |
Nifedipine is identified as a potential pharmacological modulator in Parkinson's disease by an in silico electrophysiological study
|
Mahapatra, C. |
|
|
122 |
C |
p. |
artikel |
286 |
Nomogram for Predicting the Probability of Malnutrition in Parkinson's Disease
|
Huang, Q. |
|
|
122 |
C |
p. |
artikel |
287 |
Non-invasive Peripheral Vibratory Stimulation in Attenuating Essential Tremor
|
Yan, R. |
|
|
122 |
C |
p. |
artikel |
288 |
Normative modelling reveals distinct neural correlates of olfactory and cognitive impairments in patients with Parkinson's disease: A retrospective observational study
|
Ye, R. |
|
|
122 |
C |
p. |
artikel |
289 |
Novel insights into the sex-specific role of lipid and apolipoprotein traits associated with risk of Parkinson’s disease: A prospective study
|
Zhang, S. |
|
|
122 |
C |
p. |
artikel |
290 |
NOX1 triggers ferroptosis and ferritinophagy, contributing to neurodegeneration
|
Wang, H. |
|
|
122 |
C |
p. |
artikel |
291 |
Nutritional Problems and Adaptation in Persons with Parkinson’s Disease - A Qualitative Study
|
Chen, T.-Y. |
|
|
122 |
C |
p. |
artikel |
292 |
Objective clinical registration of tremor, bradykinesia, and rigidity during awake stereotactic neurosurgery
|
Smid, A. |
|
|
122 |
C |
p. |
artikel |
293 |
Observational study of Safinamide as an add-on to levodopa monotherapy for Parkinson's disease patients with wearing-off in Japan
|
Nishikawa, N. |
|
|
122 |
C |
p. |
artikel |
294 |
Occupational impact of tardive dyskinesia (TD): Survey assessing perceptions and experiences of patients with TD and physicians who treat TD
|
Ribalov, R. |
|
|
122 |
C |
p. |
artikel |
295 |
Off-the-shelf bioreactor produced, iPSC-derived neural microtissues containing dopaminergic neurons innervate the striatum and normalize behaviour in a Parkinson rat model
|
Prudon, N. |
|
|
122 |
C |
p. |
artikel |
296 |
Olfactory and Gustatory Function is Associated with Global Cognition in Early-stage Parkinson's Disease
|
Kim, Y.E. |
|
|
122 |
C |
p. |
artikel |
297 |
Olfactory subtypes in Parkinson’s disease, and their longitudinal significance
|
Yoo, S.-W. |
|
|
122 |
C |
p. |
artikel |
298 |
Opicapone as Add-on to Levodopa in Parkinson's Patients without Motor Complications: Preliminary Data from EPSILON
|
Ferreira, J.J. |
|
|
122 |
C |
p. |
artikel |
299 |
Opicapone as First-Line Strategy for the Treatment of Wearing-off in Korean Patients with Parkinson's Disease
|
Lee, J.Y. |
|
|
122 |
C |
p. |
artikel |
300 |
Opicapone as First-Line Strategy for the Treatment of Wearing-off in Patients with Parkinson's Disease
|
Ferreira, J.J. |
|
|
122 |
C |
p. |
artikel |
301 |
Opicapone Effect on Sleep Disorders in Fluctuating Parkinson’s Disease Patients: Findings from the OASIS Trial
|
Ferreira, J.J. |
|
|
122 |
C |
p. |
artikel |
302 |
Optimizing CNS-Delivery by Lactyl Stearate-Coupled Liposomes
|
Bhargava, M. |
|
|
122 |
C |
p. |
artikel |
303 |
Optimizing DBS-Programming: A Case Study with Algorithm-Guided Strategies in Parkinson's Disease
|
Ballesteros, V. Torres |
|
|
122 |
C |
p. |
artikel |
304 |
Oscillatory subthalamic cell motor responses are associated with clinical characteristics of Parkinson’s disease
|
Nezvinskiy, A. |
|
|
122 |
C |
p. |
artikel |
305 |
Painless Legs and Moving Toes Syndrome (PLMT): A Rare Case Presentation
|
Ari, B.C. |
|
|
122 |
C |
p. |
artikel |
306 |
Pallidal Deep Brain Stimulation for Patients with Idiopathic Myoclonus Dystonia without SGCE Mutation
|
Ikezawa, J. |
|
|
122 |
C |
p. |
artikel |
307 |
Parkinsonism after Bilateral Internal Globus Pallidus Deep Brain Stimulation in Dystonia
|
Lampreia, T. |
|
|
122 |
C |
p. |
artikel |
308 |
Parkinson's disease and its financial impact on the Brazilian public health system
|
Falcão, M. Fortaleza |
|
|
122 |
C |
p. |
artikel |
309 |
Parkinson’s Disease Management in a Tertiary Irish Hospital
|
Gibbons, C. |
|
|
122 |
C |
p. |
artikel |
310 |
Parkinson’s Disease Psychosis: A systematic review of pharmacological treatment
|
Costandache, G. |
|
|
122 |
C |
p. |
artikel |
311 |
Parkinson's Disease Social Stigma Perception Scale (PDSP): Development and Pilot Study Of A Measurement Scale
|
Guerra-Anzaldo, A.L. |
|
|
122 |
C |
p. |
artikel |
312 |
Parkinson’s Disease with Hyposmia and Dysautonomia: Does It Represent a Distinct Subtype?
|
Yoon, S.H. |
|
|
122 |
C |
p. |
artikel |
313 |
Parkinson’s Disease with Hyposmia and Dysautonomia: Does It Represent a Distinct Subtype?
|
Yoon, S.H. |
|
|
122 |
C |
p. |
artikel |
314 |
Patient characteristics and real-world use of botulinum toxins for treatment of cervical dystonia and blepharospasm
|
Hast, M. |
|
|
122 |
C |
p. |
artikel |
315 |
Patient characteristics and real-world use of botulinum toxins for treatment of chronic sialorrhea
|
Hast, M. |
|
|
122 |
C |
p. |
artikel |
316 |
Patient characteristics and real-world use of botulinum toxins for treatment of hemifacial spasm
|
Hast, M. |
|
|
122 |
C |
p. |
artikel |
317 |
Patient Involvement in Parkinson’s Disease Research: Involving People with PD in the Development of a Digital Self-Management Tool
|
Olgemöller, P.M. |
|
|
122 |
C |
p. |
artikel |
318 |
Persons with Parkinson`s disease show the motor behavioral phenomenon repeated bout rate enhancement during cycling
|
Hansen, E.A. |
|
|
122 |
C |
p. |
artikel |
319 |
Pharmacist consultation in patients with Parkinson’s Disease in the outpatient clinic
|
Akkerman, M.M. |
|
|
122 |
C |
p. |
artikel |
320 |
Phenotypic characterization of Multiple System Atrophy in a multi-ethnic Asian cohort
|
Dy Closas, A.M. |
|
|
122 |
C |
p. |
artikel |
321 |
Phenotypic manifestations of KIF5A Arg1007Lys mutation: A large kindred study
|
Dulski, J. |
|
|
122 |
C |
p. |
artikel |
322 |
Phenotypic variability among siblings with heterozygous VPS13A variants
|
Lee, S. |
|
|
122 |
C |
p. |
artikel |
323 |
Phospholipase-associated neurodegeneration in India: Observations from a case series of 20 patients
|
Garg, D. |
|
|
122 |
C |
p. |
artikel |
324 |
Physical exercise as a promising enhancer of global cognition in people with Parkinson’s disease? A systematic review and meta-analysis
|
Folkerts, A.-K. |
|
|
122 |
C |
p. |
artikel |
325 |
Physiological effects of dual target DBS in an individual with Parkinson's disease and a sensing-enabled pulse generator
|
Cummins, Daniel D. |
|
|
122 |
C |
p. |
artikel |
326 |
Pimavanserin for Psychosis in Parkinson’s Disease Dementia: Subgroup Analysis of the HARMONY Trial
|
Weintraub, D. |
|
|
122 |
C |
p. |
artikel |
327 |
Plasma neurofilament light chain level in isolated REM sleep behavior disorders, Parkinson’s disease and multiple system atrophy
|
Calculli, A. |
|
|
122 |
C |
p. |
artikel |
328 |
Plasma proteomic profiles and risk of Parkinson's disease
|
Li, C. |
|
|
122 |
C |
p. |
artikel |
329 |
Population pharmacokinetic analysis of BIA 28-6156, an allosteric activator of beta-glucocerebrosidase (GCase), in Parkinson’s Disease patients and healthy volunteers
|
Ronaghinia, A.A. |
|
|
122 |
C |
p. |
artikel |
330 |
“Pop-up” studies: Observational studies in Huntington disease conducted at annual family convention
|
Sathe, S. |
|
|
122 |
C |
p. |
artikel |
331 |
Posterior cortical atrophy with biomarkers of Alzheimer's disease presenting with corticobasal syndrome and Balint syndrome - A case report
|
Vo, K.N.C. |
|
|
122 |
C |
p. |
artikel |
332 |
Predicting Impulsivity in Parkinson’s Disease Patients
|
Chen, S. |
|
|
122 |
C |
p. |
artikel |
333 |
Predicting the optimal deep brain stimulation contact-level in Parkinson's disease: Insights from local field potentials recorded by the implanted neurostimulator
|
Muller, M. |
|
|
122 |
C |
p. |
artikel |
334 |
Pregnancy in dystonia or Tourette’s patients treated with DBS. Four new cases and a review of the literature
|
Mehanna, R. |
|
|
122 |
C |
p. |
artikel |
335 |
Prevalence of Autonomic Symptoms in a Mexican Population with Parkinson's Disease
|
Dominguez-Garcia, A. |
|
|
122 |
C |
p. |
artikel |
336 |
Prevalence of non-motor symptoms and their impact on quality of life in PD: A Mexican Registry, 2011-2019 (the ReMePark-2 study)
|
Romero Terán, D.P. |
|
|
122 |
C |
p. |
artikel |
337 |
Prevalence of tardive dysmentia & tardive dyskinesia in patients with schizophrenia
|
Nayak, M. |
|
|
122 |
C |
p. |
artikel |
338 |
Processing Speed Mediates the Relationship between Apathy and Emotion Recognition in Parkinson’s Disease
|
Zabala-Gomez, O. |
|
|
122 |
C |
p. |
artikel |
339 |
Prodromal and Overt Parkinson’s Disease Epidemiological Study in Brazil (PROBE-PD study): Preliminary Results
|
Pedrosa, L.R.R. |
|
|
122 |
C |
p. |
artikel |
340 |
Profile of Glucocerebrosidase 1 (GCASE) activity and Glucosylsphingosine levels in GBA-PD, PD patients and healthy volunteers
|
Pires, N. |
|
|
122 |
C |
p. |
artikel |
341 |
Profile of patients with advanced Parkinson’s disease treated with Levodopa–entacapone–carbidopa intestinal gel (LECIG)
|
Szász, J. |
|
|
122 |
C |
p. |
artikel |
342 |
Progressive Encephalomyelitis with Rigidity and Myoclonus in a Varicella Encephalitis patient with Primary Meige syndrome
|
Jayasree, M. |
|
|
122 |
C |
p. |
artikel |
343 |
Progressive Encephalomyelitis with Rigidity and Myoclonus In a Varicella Encephalitis Patient with Primary Meige syndrome
|
Jayasree, M. |
|
|
122 |
C |
p. |
artikel |
344 |
Progressive QTc prolongation and reduced heart rate variability in dementia with Lewy bodies compared to Alzheimer's disease
|
Haglund, Mattias |
|
|
122 |
C |
p. |
artikel |
345 |
Protective potential of laughter yoga and clapping exercises on stress level and motor functions in Parkinson’s disease patients with type 2 diabetes
|
Kumar, R. |
|
|
122 |
C |
p. |
artikel |
346 |
Psychometric Validation of the Mild Behavioral Impairment Checklist (MBI-C) in Parkinson’s Disease
|
Pinilla-Monsalve, G.D. |
|
|
122 |
C |
p. |
artikel |
347 |
Psychomotor delay: Expanding the neurological phenotype of ATP13A2-related disorders
|
Silva, L. |
|
|
122 |
C |
p. |
artikel |
348 |
QI Project introducing A Reflective-Education Model Optimizing Palliative Care Delivery: A Multidisciplinary and Primary Care Integration Model
|
Bacorro, M. |
|
|
122 |
C |
p. |
artikel |
349 |
Quality of Life in Parkinson’s Disease: Examining the Influence of the Intersection between Health-Related Quality of Life and Clinical Metrics
|
Kuanar, G. |
|
|
122 |
C |
p. |
artikel |
350 |
Quebec Parkinson Network: The reference for your next research in Parkinson's disease and related disorders
|
Bogard, S. |
|
|
122 |
C |
p. |
artikel |
351 |
Recent advances in non-Huntington's disease choreas
|
Cincotta, Molly C. |
|
|
122 |
C |
p. |
artikel |
352 |
Recrudescence of a compensated hemidystonia-hemiatrophy syndrome after COVID-19 infection
|
Kundrick, A. |
|
|
122 |
C |
p. |
artikel |
353 |
Refining the clinical diagnosis of Parkinson's disease
|
Mulroy, Eoin |
|
|
122 |
C |
p. |
artikel |
354 |
Relation between Clinical and Electrophysiological Correlates of Peripheral Polyneuropathy and Oral Levodopa Treatment in People with Parkinson’s Disease
|
Déry, C. |
|
|
122 |
C |
p. |
artikel |
355 |
Relationship between agricultural vulnerability to organic compound fungicides and herbicides and Parkinson's disease incidence in a rural population in northern India
|
Sharma, M. |
|
|
122 |
C |
p. |
artikel |
356 |
Retro-Walking and Cholinergic System Changes in Parkinson's Disease
|
Griggs, A. |
|
|
122 |
C |
p. |
artikel |
357 |
Rheumatoid Arthritis and Risk of Parkinson’s disease in the UK Biobank: A Prospective Study
|
Zheng, X. |
|
|
122 |
C |
p. |
artikel |
358 |
Right Default Mode Network Functional Instability Predicts Poorer Executive Function in Parkinson’s Disease
|
Roytman, S. |
|
|
122 |
C |
p. |
artikel |
359 |
Right to the Point - A Writer’s Cramp Successful Treatment
|
Duarte, A. |
|
|
122 |
C |
p. |
artikel |
360 |
Risk factors for Parkinson's disease and Parkinson's disease with cognitive impairment in high altitude: A case-control study
|
Zhu, A. |
|
|
122 |
C |
p. |
artikel |
361 |
Risk of developing Parkinson's disease and early stage diagnosis through the primary healthcare system
|
Akramova, D. |
|
|
122 |
C |
p. |
artikel |
362 |
Role of estrogen and progesterone on neuronal parameters and behavioral impairments in different age groups of naturally menopausal rats: A behavioral, biochemical and ultrastructural study
|
Kumar, P. |
|
|
122 |
C |
p. |
artikel |
363 |
Role of linagliptin, a dipeptidyl peptidase-4 inhibitor against oxidative stress and neuronal damage in experimental diabetic aging brain of female rats of different age groups.
|
Kumar, P. |
|
|
122 |
C |
p. |
artikel |
364 |
Role of pharmacological therapy on bone mineral density and postural instability in post-menopausal women with Parkinson’s disease
|
Rajput, R. |
|
|
122 |
C |
p. |
artikel |
365 |
Role of telemedicine- versus outpatient-based initiation and management of Atkins diet therapy in middle aged women with drug-resistant Parkinson's disease during the COVID-19 pandemic
|
Sharma, M. |
|
|
122 |
C |
p. |
artikel |
366 |
Role Of Wearable Technology And Geo-Fencing Device For Analyses of Movement And Memory Data In Huntington's Disease Patients In Gurugram City, India
|
Sharma, V. |
|
|
122 |
C |
p. |
artikel |
367 |
Safety, Tolerability, and Clinical Assessment of Bemdaneprocel for Parkinson’s Disease: 18-Month Results From a Phase 1 Study
|
Fasano, A. |
|
|
122 |
C |
p. |
artikel |
368 |
Saving dopaminergic neurons from endoplasmic reticulum (ER) stress - A breakthrough approach to fight Parkinson's disease
|
Gentile, L. |
|
|
122 |
C |
p. |
artikel |
369 |
SCA4: Correlation of age of onset and ZFHX3 repeat length
|
Wallenius, J. |
|
|
122 |
C |
p. |
artikel |
370 |
Selective Brain Iron Deposition in Individuals with a History of Methamphetamine Abuse
|
Kelley, L. |
|
|
122 |
C |
p. |
artikel |
371 |
Sexual dysfunction in patients with focal dystonia
|
Kalniņa, M. |
|
|
122 |
C |
p. |
artikel |
372 |
Should Serum NMO Antibody Testing Be Part Of The Initial Work-up In Adult Onset Cerebellar Ataxia
|
Tar, M. |
|
|
122 |
C |
p. |
artikel |
373 |
Singing training in people with Parkinson's disease: A feasibility study
|
Trinchillo, A. |
|
|
122 |
C |
p. |
artikel |
374 |
Sleep Biomarker-Based Characterization of Neurodegenerative Disorder Risk in Parkinsonian Spectrum Disorder Patients
|
Levendowski, D. |
|
|
122 |
C |
p. |
artikel |
375 |
Sleep disturbances are associated with accelerated postural instability and death in Parkinson’s disease
|
Griti, S.A. |
|
|
122 |
C |
p. |
artikel |
376 |
Somnolence-Related Events Over Time During Valbenazine Treatment for Chorea Associated with Huntington’s Disease
|
Stimming, E. Furr |
|
|
122 |
C |
p. |
artikel |
377 |
Specific features of behavioral disorders in Parkinson's disease
|
Naimov, O. |
|
|
122 |
C |
p. |
artikel |
378 |
Spectrum of movement disorders, imaging findings in SSPE and response to therapy – A prospective cohort study
|
Elavarasi, A. |
|
|
122 |
C |
p. |
artikel |
379 |
Speech Biomarkers for Dysarthria in Parkinson's Disease — Clinical Validation Across Spanish and Czech Languages
|
Baykara, E. |
|
|
122 |
C |
p. |
artikel |
380 |
Spinocerebellar ataxia type 3 (MJD) without distinct parkinsonism showing presynaptic dopamine transporter (DAT) uptake loss
|
Park, M. |
|
|
122 |
C |
p. |
artikel |
381 |
Sporadic Creutzfeldt-Jakob disease: A Retrospective Analysis of 27 cases in Vietnam
|
Bui, N. |
|
|
122 |
C |
p. |
artikel |
382 |
Start Right, Stay Well: Piloting a Screening Tool for Dysphagia and Medication Management for Patients with Parkinson's in the Emergency Department
|
Hornby, H. |
|
|
122 |
C |
p. |
artikel |
383 |
STAT3-mediated ferroptosis is involved in α-synuclein pathology
|
Lin, D. |
|
|
122 |
C |
p. |
artikel |
384 |
Striatal dopaminergic degeneration and motor and cognitive symptoms in de novo Parkinson’s Disease: An 18F-DOPA PET study
|
De Meyer, E. |
|
|
122 |
C |
p. |
artikel |
385 |
Structural correlates of survival in progressive supranuclear palsy
|
Street, D. |
|
|
122 |
C |
p. |
artikel |
386 |
Studying the relationship between different stages of Parkinson's disease and iron metabolism, oxidative stress, and inflammation from Qinghai-Tibetan Plateau Area
|
Yan, L. |
|
|
122 |
C |
p. |
artikel |
387 |
Study of 17β estradiol with neuropeptide and amyloid beta fragment on neuronal and biochemical functions in naturally menopausal aging rats
|
Kumar, P. |
|
|
122 |
C |
p. |
artikel |
388 |
Study of the Neuroprotective Potential of gallic acid in the Mouse Model of Parkinson’s Disease
|
Rajput, S. |
|
|
122 |
C |
p. |
artikel |
389 |
Study protocol: Exploration of sternal focused vibrotactile stimulation in people with Parkinson's disease experiencing Freezing of Gait
|
Wilhelm, A. |
|
|
122 |
C |
p. |
artikel |
390 |
Subthalamic activity in Park2-associated early-onset Parkinson’s disease
|
Pavlovsky, P. |
|
|
122 |
C |
p. |
artikel |
391 |
Suicide Attempt in a Case of Dopamine Agonist Withdrawal Syndrome in Parkinson's Disease
|
Espindola, M. |
|
|
122 |
C |
p. |
artikel |
392 |
Sustained release triple drug loaded Colloidosomes for management of Parkinson’s Disease
|
Bhargava, S. |
|
|
122 |
C |
p. |
artikel |
393 |
Systemic inflammation and the risk of multiple system atrophy: A prospective cohort study
|
Zhang, S. |
|
|
122 |
C |
p. |
artikel |
394 |
Tai Chi improves non-motor symptoms of Parkinson's disease: One-year randomized controlled study with the investigation of mechanisms
|
Li, G. |
|
|
122 |
C |
p. |
artikel |
395 |
Targeting sedentary behavior decreases depressive symptoms and improves sleep in people with Parkinson’s Disease
|
van Emde Boas, M. |
|
|
122 |
C |
p. |
artikel |
396 |
Targeting sedentary behavior decreases depressive symptoms and improves sleep in people with Parkinson’s Disease
|
van Emde Boas, M. |
|
|
122 |
C |
p. |
artikel |
397 |
TeleHD: Feasibility, Validity and Value of Telemedicine in Huntington Disease
|
Deliz-Gonzalez, J. |
|
|
122 |
C |
p. |
artikel |
398 |
Telehealth Follow-up for Cervical Dystonia Patients Treated with Neurotoxin Injection: Patient Reported Outcomes
|
Harper, K. |
|
|
122 |
C |
p. |
artikel |
399 |
Testing gene-environment interaction in PD using whole-genome sequencing (WGS) of pesticide-exposed cohorts
|
Goldman, S. |
|
|
122 |
C |
p. |
artikel |
400 |
TGF-β1 Provides Neuroprotection via Inhibition of Microglial Activation in 3-Acetylpyridine-Induced Cerebellar Ataxia Model Rats
|
Cao, B.-B. |
|
|
122 |
C |
p. |
artikel |
401 |
The association of olfactory dysfunction with depression in patients with early-onset Parkinson`s disease
|
Thi Huyen, T. Dang |
|
|
122 |
C |
p. |
artikel |
402 |
The association of olfactory dysfunction with depression in patients with early-onset Parkinson`s disease
|
Thi Huyen, T. Dang |
|
|
122 |
C |
p. |
artikel |
403 |
The Association of Radiological Features to Predominant Cognitive Clinical Syndromes of Lewy Body Dementia
|
Uyanik, O. |
|
|
122 |
C |
p. |
artikel |
404 |
The brain fMRI study of patients with Parkinson's disease and pain induced by contact heat stimulations
|
Qiao-Jun, P. |
|
|
122 |
C |
p. |
artikel |
405 |
The characteristic and prognostic role of blood inflammatory markers in patients with Huntington's disease from China
|
Cheng, Y. |
|
|
122 |
C |
p. |
artikel |
406 |
The Characteristics of Autonomic Dysfunction in Progressive Supranuclear Palsy: A Retrospective Study
|
Wang, Y. |
|
|
122 |
C |
p. |
artikel |
407 |
The cingulate island sign in a mixed memory clinical cohort: Prevalence and diagnostic accuracy
|
Feng, Linda Ruohua |
|
|
122 |
C |
p. |
artikel |
408 |
The clinical features, neuroimaging and outcomes of diabetic striatopathy: A retrospective study at a tertiary hospital in Vietnam
|
Nguyen, N. |
|
|
122 |
C |
p. |
artikel |
409 |
The Correlation between Nutritional Status and Quality of Life in Persons with Parkinson’s disease
|
Ouyang, C.-M. |
|
|
122 |
C |
p. |
artikel |
410 |
The effect of intraoperative monitoring on final electrode placement in movement disorder patients treated with deep brain stimulation
|
Ibrulj, S. |
|
|
122 |
C |
p. |
artikel |
411 |
The efficacy of Safinamide in improving motor symptoms and the quality of life in Korean patients with motor fluctuations
|
Kwon, D.-Y. |
|
|
122 |
C |
p. |
artikel |
412 |
The Elevated Risk of Dementia in Parkinson's Disease Patients Associated with Metabolic Syndrome
|
Tur, E. Kobak |
|
|
122 |
C |
p. |
artikel |
413 |
The feasibility of sequential remote motor evaluations of people with possible Parkinson’s disease and related conditions
|
Elshourbagy, A. |
|
|
122 |
C |
p. |
artikel |
414 |
The greater loss of ability to detect unpleasant smells may be related to the risk of more severe PD symptoms
|
Chiu, S.-C. |
|
|
122 |
C |
p. |
artikel |
415 |
The impact of short-term blood pressure variability on dementia in Parkinson’s disease in relation to the renin-angiotensin system
|
Kwasniak-Butowska, M. |
|
|
122 |
C |
p. |
artikel |
416 |
The influence of robotics and modern technologies to assist individuals with Parkinson's disease
|
Kim, A. |
|
|
122 |
C |
p. |
artikel |
417 |
The Link between COVID-19 and Parkinsonism: A Case Series
|
Khalid, S.H. |
|
|
122 |
C |
p. |
artikel |
418 |
The long-term response to botulinum toxin injections in patients with blepharospasm undergoing upper eyelid surgery
|
Trinchillo, A. |
|
|
122 |
C |
p. |
artikel |
419 |
The PD-HI: Development and Validation of a Novel, Disease-Specific Patient-Reported Outcome Measure for Parkinson’s Disease Clinical Trials
|
Seabury, J. |
|
|
122 |
C |
p. |
artikel |
420 |
The phenotypic spectra of polyQ expansion versus non-expansion forms in spinocerebellar ataxias
|
Moura, J. |
|
|
122 |
C |
p. |
artikel |
421 |
The phosphodiesterase inhibitor, ibudilast ameliorates Huntington's disease pathology by modulating neuroinflammation and signaling pathway in a rat model
|
Kumar, A. |
|
|
122 |
C |
p. |
artikel |
422 |
The potential use of plasma GFAP as a diagnostic and prognostic biomarker of motor subtype in early Parkinson’s disease
|
Che, N. |
|
|
122 |
C |
p. |
artikel |
423 |
Therapeutic benefit of laughter yoga and deep breathing exercises with oral doses of Withania somnifera root extracts in Parkinson's disease patients.
|
Kumar, R. |
|
|
122 |
C |
p. |
artikel |
424 |
Therapeutic effects of hyperbaric oxygen on Parkinson disease - A systematic review and meta-analysis.
|
Zhao, Q. |
|
|
122 |
C |
p. |
artikel |
425 |
The role of brain-derived neurotrophic factor during Parkinson's disease
|
Holmuratova, B. |
|
|
122 |
C |
p. |
artikel |
426 |
The role of neurotrophic factors in development Parkinson's disease dementia
|
Okhunova, D. |
|
|
122 |
C |
p. |
artikel |
427 |
The role of Parkin for neuroprotection in TAF15-induced proteinopathy
|
Choi, E.J. |
|
|
122 |
C |
p. |
artikel |
428 |
The role of semispinalis capitis muscles in cervical dystonia with goose-neck posture
|
Vu, H. |
|
|
122 |
C |
p. |
artikel |
429 |
The significance of mineral mass imbalances in cognitive dysfunctions associated with vascular parkinsonism
|
Akramova, D. |
|
|
122 |
C |
p. |
artikel |
430 |
Theta-alpha STN oscillations are associated with motor signs of Parkinson’s disease
|
Sayfulina, K. |
|
|
122 |
C |
p. |
artikel |
431 |
The use of botulinum toxin A in the treatment of hand tremor
|
Peshkin, A. |
|
|
122 |
C |
p. |
artikel |
432 |
The use of diffusion tensor tomography (DTI) to assess the recovery of Pyramidal system
|
Peshkin, A. |
|
|
122 |
C |
p. |
artikel |
433 |
The vestibulospinal dysfunction has little impact on falls in patients with mild Parkinson's disease
|
Hong, Jun-Pyo |
|
|
122 |
C |
p. |
artikel |
434 |
Time perception reflects individual differences in motor and non-motor symptoms of Parkinson’s disease
|
Kishida, K. |
|
|
122 |
C |
p. |
artikel |
435 |
TMEM106B aggravates symptoms of Parkinson’s disease by regulating the autophagy-lysosome pathway
|
Xie, A. |
|
|
122 |
C |
p. |
artikel |
436 |
TMEM106B knockdown exhibits a neuroprotective effect in Parkinson’s disease via decreasing inflammation and iron deposition
|
Liu, Y. |
|
|
122 |
C |
p. |
artikel |
437 |
Topography of cholinergic system changes associated with visuomotor-cognitive multitasking simulating real-life mobility in Parkinson’s disease
|
Biddix, A. |
|
|
122 |
C |
p. |
artikel |
438 |
TorsinA-interacting protein 2 (TOR1AIP2) variants in an autosomal dominant combined dystonia-hemichorea-hemiballismus syndrome in two families
|
Kafantari, E. |
|
|
122 |
C |
p. |
artikel |
439 |
Total Physical Activity, Plant-based Diet and Neurodegenerative Diseases: A Prospective Cohort Study of the UK Biobank
|
Zheng, X. |
|
|
122 |
C |
p. |
artikel |
440 |
To test or not to test: Assessing olfaction in Parkinson’s disease based on patient reports
|
Sari, H.K. |
|
|
122 |
C |
p. |
artikel |
441 |
Towards a biological diagnosis of PD
|
Chopra, Avika |
|
|
122 |
C |
p. |
artikel |
442 |
Trajectory of Motor progression pursuant to temporal dynamic status of cardiac denervation in Parkinson’s disease
|
Yoo, S.-W. |
|
|
122 |
C |
p. |
artikel |
443 |
Trajectory of Motor progression pursuant to temporal dynamic status of cardiac denervation in Parkinson’s disease
|
Yoo, S.-W. |
|
|
122 |
C |
p. |
artikel |
444 |
Transformation of clinical forms and stages of Parkinson's disease against the background of Covid-19 infection
|
Matmurodov, R. |
|
|
122 |
C |
p. |
artikel |
445 |
Treatment of Hemimasticatory Spasm and Facial Myokymia Associated with Hemifacial Atrophy and Localized Morphea with Botulinum Neurotoxin and Immunotherapy
|
Mustafa, F. |
|
|
122 |
C |
p. |
artikel |
446 |
Treg Cells Attenuate Neuroinflammation and Protect Neurons in a Mouse Model of Parkinson's Disease
|
Huang, Y. |
|
|
122 |
C |
p. |
artikel |
447 |
TREM2 deficiency aggravates neuroinflammatory response and cognitive impairment via disease-associated microglia in Parkinson’s disease
|
Zhang, P. |
|
|
122 |
C |
p. |
artikel |
448 |
Two parallel nigrostriatal subcircuits mediate arousal effect of dopaminergic neurons in substantia nigra pars compacta
|
Liu, H. |
|
|
122 |
C |
p. |
artikel |
449 |
Unawareness of hyposmia in people with and without Parkinson`s disease
|
Thi Huyen, T. Dang |
|
|
122 |
C |
p. |
artikel |
450 |
Understanding Fall Perceptions Among People with Parkinson’s Disease: A Systematic Qualitative Review
|
Ng, Q.X. |
|
|
122 |
C |
p. |
artikel |
451 |
Understand the connection between oxidative stress levels and mitochondrial gene mutations in Parkinson’s disease patients
|
Balachandar, M. |
|
|
122 |
C |
p. |
artikel |
452 |
Unraveling the Diagnostic Enigma: Stiff Person Syndrome or axial dystonia?
|
Jacheva, I. |
|
|
122 |
C |
p. |
artikel |
453 |
Unraveling the Genetic Landscape of Undiagnosed Cerebellar Ataxia in Brazilian Patients
|
Novis, L.E. |
|
|
122 |
C |
p. |
artikel |
454 |
Unusual rapid progression of cognitive function in young-onset Parkinson’s disease: A case report
|
Tsuboi, R. |
|
|
122 |
C |
p. |
artikel |
455 |
Unveiling Cholinergic Brain changes associated with Visuo-Constructive Deficits in Parkinson's Disease: A Focus on the Hooper Test
|
van Emde Boas, M. |
|
|
122 |
C |
p. |
artikel |
456 |
Unveiling the Complexity of Parkinson's Disease: Exploring Subtypes and Tracing its Five-Stage Natural Course
|
Abduraimov, K. |
|
|
122 |
C |
p. |
artikel |
457 |
Updates in essential tremor
|
Okelberry, Tyler |
|
|
122 |
C |
p. |
artikel |
458 |
Ups and Downs, Joys and Sorrows: Assessing Patient Priorities in an Interdisciplinary PD Clinic
|
Trahair, E. |
|
|
122 |
C |
p. |
artikel |
459 |
Usage of modern technologies like VR therapy, physio therapy along with levodopa in Young-Onset Parkinson's disease patients
|
Pavihran, D. |
|
|
122 |
C |
p. |
artikel |
460 |
User-Centric Design of a Biochemical Sensor for Parkinson's Disease: A Survey-Based Approach to Understand Community Expectations and Values
|
Dupre, B. |
|
|
122 |
C |
p. |
artikel |
461 |
Validation of GWAS-Identified Risk Loci for Parkinson’s Disease in the Chinese Population
|
Li, C. |
|
|
122 |
C |
p. |
artikel |
462 |
Validation of models for assessing eligibility for referral for Device-Aided Treatment in Parkinson's disease (VALIDATE)
|
Moes, H. |
|
|
122 |
C |
p. |
artikel |
463 |
Validation of Strategies for Measuring Blood Glucocerebrosidase Enzyme Activity in Parkinson's Disease with GBA1 Variant
|
Park, K.-S. |
|
|
122 |
C |
p. |
artikel |
464 |
Validation of the Polish Version of the Gastrointestinal Dysfunction Scale for Parkinson's Disease
|
Nowak, J.M. |
|
|
122 |
C |
p. |
artikel |
465 |
Variations in total body fluid and mineral mass in different forms of Parkinson`s disease
|
Akramova, D. |
|
|
122 |
C |
p. |
artikel |
466 |
Vascular remodeling in patients with CKD as a risk factor for the development of vascular Parkinsonism
|
Khudayarova, S. |
|
|
122 |
C |
p. |
artikel |
467 |
Wait and see... is it multiple system atrophy type C? A case report
|
Grilo, P. |
|
|
122 |
C |
p. |
artikel |
468 |
When Jerks and Stumbles Become More Than Just Clumsiness
|
Desai, S. |
|
|
122 |
C |
p. |
artikel |
469 |
Whole exome sequencing and clinical investigation of young onset dystonia: What can we learn?
|
Park, J. |
|
|
122 |
C |
p. |
artikel |
470 |
Withdrawn
|
|
|
|
122 |
C |
p. |
artikel |
471 |
Withdrawn
|
|
|
|
122 |
C |
p. |
artikel |
472 |
Withdrawn
|
|
|
|
122 |
C |
p. |
artikel |
473 |
WITHDRAWN
|
|
|
|
122 |
C |
p. |
artikel |
474 |
Withdrawn
|
|
|
|
122 |
C |
p. |
artikel |